Cargando…

Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries, and strongly associated with type 2 diabetes mellitus (T2DM). Several studies have shown that hypoglycemic agents are effective for NAFLD combined with T2DM. However, there i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Su-Tong, Su, Kai-Qi, Zhang, Li-Hui, Liu, Ming-Hao, Zhao, Wen-Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593046/ https://www.ncbi.nlm.nih.gov/pubmed/32769900 http://dx.doi.org/10.1097/MD.0000000000021568

Ejemplares similares

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis
por: Dai, Wenjie, et al.
Publicado: (2017)

Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque
por: Yu, Lo-Yip, et al.
Publicado: (2019)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Xiaochaihu decoction for nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis
por: Zhu, Wenyu, et al.
Publicado: (2021)

Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease: A systematic review and meta-analysis of 16 RCTs
por: Zhao, Yan, et al.
Publicado: (2023)

Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease
por: Al-Qarni, Reem, et al.
Publicado: (2020)

Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: A systematic review and meta-analysis
por: Saokaew, Surasak, et al.
Publicado: (2021)

Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults: A Large Population-Based Study
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
por: Zhou, Xiangyu, et al.
Publicado: (2023)

Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article
por: Lin, Ying-Chun, et al.
Publicado: (2021)

Changes in Tumor Necrosis Factor-α, Heat Shock Protein 70, Malondialdehyde, and Superoxide Dismutase in Patients With Different Severities of Alcoholic Fatty Liver Disease: A Prospective Observational Study
por: Qu, Bao-Ge, et al.
Publicado: (2015)

Efficacy and safety of incretin-based therapies in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis
por: Fan, Si-min, et al.
Publicado: (2020)

Efficacy and safety of Yinchenwuling Powder for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Wu, Peishan, et al.
Publicado: (2022)

Hemolytic anemia in alcoholic liver disease: Zieve syndrome: A case report and literature review
por: Liu, Miao-Xia, et al.
Publicado: (2017)

Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis
por: Qi, Shan, et al.
Publicado: (2017)

External validation of non-invasive prediction models for identifying ultrasonography-diagnosed fatty liver disease in a Chinese population
por: Shen, Ya-Nan, et al.
Publicado: (2017)

The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials
por: Zhou, Jingwen, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: A Negative Risk Factor for Colorectal Cancer Prognosis
por: You, Jie, et al.
Publicado: (2015)

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Pang, Qing, et al.
Publicado: (2015)

Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese
por: Huang, Xiaolin, et al.
Publicado: (2015)

Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
por: Xiong, Pian, et al.
Publicado: (2021)

Statins on nonalcoholic fatty liver disease: A systematic review and meta-analysis of 14 RCTs
por: Zhou, Haiyan, et al.
Publicado: (2023)

The comparison of accuracy and practicability between ultrasound and spiral CT in the diagnosis of intestinal obstruction: A protocol for systematic review and meta-analysis
por: Yang, Qingya, et al.
Publicado: (2021)

Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease
por: Wang, Qi, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index
por: Chung, Goh Eun, et al.
Publicado: (2015)

Metabolic status indicators and influencing factors in non-obese, non-centrally obese nonalcoholic fatty liver disease
por: Huang, Zhipeng, et al.
Publicado: (2023)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in the blood: A protocol for systematic review and meta-analysis
por: Han, Xu, et al.
Publicado: (2022)

The influence of RS738409 I148M polymorphism of patatin-like phospholipase domain containing 3 gene on the susceptibility of non-alcoholic fatty liver disease
por: Akkiz, Hikmet, et al.
Publicado: (2021)

Efficacy and safety of milk thistle preventive treatment of anti-tuberculosis drug-induced liver injury: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2020)

Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
por: Wu, Sheng-Jie, et al.
Publicado: (2015)

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis
por: Sawangjit, Ratree, et al.
Publicado: (2016)

Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review
por: Xie, Qingxing, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Risk factors of nonalcoholic fatty liver disease in healthy women
por: Guan, Hui, et al.
Publicado: (2023)

Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients
por: Yu, Haifeng, et al.
Publicado: (2021)

Acupoint embedding therapy improves nonalcoholic fatty liver disease with abnormal transaminase: A PRISMA-compliant systematic review and meta-analysis
por: Dai, Liang, et al.
Publicado: (2020)

Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis?
por: Wei, Lin, et al.
Publicado: (2021)

Association between nonalcoholic fatty liver disease and colorectal cancer: A population-based study
por: Wu, Po-Hsien, et al.
Publicado: (2023)

Auricular therapy improves gastrointestinal function in patients with gynecological laparoscopic surgery: A protocol for systematic review and meta analysis
por: Hu, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_89ko16lmrnmch7n54r14n0bnab